Timothy Brennan

2.0k total citations
18 papers, 1.5k citations indexed

About

Timothy Brennan is a scholar working on Virology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Timothy Brennan has authored 18 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Virology, 9 papers in Epidemiology and 8 papers in Infectious Diseases. Recurrent topics in Timothy Brennan's work include HIV Research and Treatment (9 papers), HIV/AIDS drug development and treatment (5 papers) and Immune Cell Function and Interaction (5 papers). Timothy Brennan is often cited by papers focused on HIV Research and Treatment (9 papers), HIV/AIDS drug development and treatment (5 papers) and Immune Cell Function and Interaction (5 papers). Timothy Brennan collaborates with scholars based in United States and Sweden. Timothy Brennan's co-authors include Robert F. Siliciano, Janet D. Siliciano, Stuart C. Ray, Justin R. Bailey, Claus O. Wilke, Ahmad R. Sedaghat, Karen A. O’Connell, Megan Wind‐Rotolo, Joel N. Blankson and Mary F. Kearney and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Clinical Infectious Diseases.

In The Last Decade

Timothy Brennan

18 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Timothy Brennan United States 13 1.1k 969 390 367 173 18 1.5k
M. Koot Netherlands 13 1.4k 1.2× 892 0.9× 336 0.9× 722 2.0× 129 0.7× 21 1.6k
J J de Jong Netherlands 12 1.3k 1.1× 887 0.9× 250 0.6× 402 1.1× 94 0.5× 15 1.4k
Maarten Koot Netherlands 17 1.7k 1.5× 1.2k 1.2× 494 1.3× 684 1.9× 169 1.0× 20 2.0k
Lorraine Peddada United States 7 855 0.7× 769 0.8× 518 1.3× 175 0.5× 260 1.5× 7 1.3k
Catherine Tamalet France 22 813 0.7× 715 0.7× 345 0.9× 204 0.6× 208 1.2× 49 1.3k
Holly Bazmi United States 8 1.4k 1.2× 1.3k 1.4× 355 0.9× 202 0.6× 97 0.6× 9 1.7k
Richard Smith United States 8 853 0.7× 822 0.8× 660 1.7× 173 0.5× 395 2.3× 10 1.5k
Theresa Shea United States 7 1.3k 1.1× 847 0.9× 300 0.8× 592 1.6× 47 0.3× 8 1.4k
Mary N. Phillips United States 7 1.3k 1.1× 699 0.7× 325 0.8× 835 2.3× 59 0.3× 7 1.5k
Astrid K. N. Iversen Denmark 21 1.5k 1.3× 1.1k 1.2× 372 1.0× 475 1.3× 73 0.4× 39 1.8k

Countries citing papers authored by Timothy Brennan

Since Specialization
Citations

This map shows the geographic impact of Timothy Brennan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy Brennan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy Brennan more than expected).

Fields of papers citing papers by Timothy Brennan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy Brennan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy Brennan. The network helps show where Timothy Brennan may publish in the future.

Co-authorship network of co-authors of Timothy Brennan

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy Brennan. A scholar is included among the top collaborators of Timothy Brennan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy Brennan. Timothy Brennan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Wang, Zheng, Timothy Brennan, Jeffrey M. Gerold, et al.. (2018). Expanded cellular clones carrying replication-competent HIV-1 persist, wax, and wane. Proceedings of the National Academy of Sciences. 115(11). 157 indexed citations
2.
Salgado, María, Timothy Brennan, Karen A. O’Connell, et al.. (2010). Evolution of the HIV-1 nefgene in HLA-B*57 Positive Elite Suppressors. Retrovirology. 7(1). 94–94. 32 indexed citations
3.
O’Connell, Karen A., Timothy Brennan, Justin R. Bailey, et al.. (2010). Control of HIV-1 in Elite Suppressors despite Ongoing Replication and Evolution in Plasma Virus. Journal of Virology. 84(14). 7018–7028. 99 indexed citations
4.
Dinoso, Jason B., Ann Wiegand, Sarah Palmer, et al.. (2009). Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy. Proceedings of the National Academy of Sciences. 106(23). 9403–9408. 343 indexed citations
5.
Brennan, Timothy, John O. Woods, Ahmad R. Sedaghat, et al.. (2009). Analysis of Human Immunodeficiency Virus Type 1 Viremia and Provirus in Resting CD4 + T Cells Reveals a Novel Source of Residual Viremia in Patients on Antiretroviral Therapy. Journal of Virology. 83(17). 8470–8481. 103 indexed citations
6.
Begier, Elizabeth, M. Steven Oberste, Marie L. Landry, et al.. (2008). An Outbreak of Concurrent Echovirus 30 and Coxsackievirus A1 Infections Associated with Sea Swimming among a Group of Travelers to Mexico. Clinical Infectious Diseases. 47(5). 616–623. 33 indexed citations
7.
Bailey, Justin R., Timothy Brennan, Karen A. O’Connell, Robert F. Siliciano, & Joel N. Blankson. (2008). Evidence of CD8 + T-Cell-Mediated Selective Pressure on Human Immunodeficiency Virus Type 1 nef in HLA-B*57 + Elite Suppressors. Journal of Virology. 83(1). 88–97. 50 indexed citations
8.
McMahon, Moira A., Benjamin L. Jilek, Timothy Brennan, et al.. (2007). The HBV Drug Entecavir — Effects on HIV-1 Replication and Resistance. New England Journal of Medicine. 356(25). 2614–2621. 190 indexed citations
9.
Johnson, Tory P., et al.. (2007). Development of an aciclovir implant for the effective long-term control of herpes simplex virus type-1 infection in Vero cells and in experimentally infected SKH-1 mice. International Journal of Antimicrobial Agents. 30(5). 428–435. 10 indexed citations
10.
Sedaghat, Ahmad R., Janet D. Siliciano, Timothy Brennan, Claus O. Wilke, & Robert F. Siliciano. (2007). Limits on Replenishment of the Resting CD4+ T Cell Reservoir for HIV in Patients on HAART. PLoS Pathogens. 3(8). e122–e122. 59 indexed citations
11.
Bailey, Justin R., Ahmad R. Sedaghat, Tara L. Kieffer, et al.. (2006). Residual Human Immunodeficiency Virus Type 1 Viremia in Some Patients on Antiretroviral Therapy Is Dominated by a Small Number of Invariant Clones Rarely Found in Circulating CD4 + T Cells. Journal of Virology. 80(13). 6441–6457. 335 indexed citations
12.
Hadler, James L., Kathleen G. Julian, Stephen J. Walsh, et al.. (2001). West Nile Virus Serosurvey and Assessment of Personal Prevention Efforts in an Area with Intense Epizootic Activity: Connecticut, 2000. Annals of the New York Academy of Sciences. 951(1). 307–316. 31 indexed citations
13.
Mayo, Donald R., et al.. (2001). Jamestown Canyon Virus: Seroprevalence in Connecticut. Emerging infectious diseases. 7(5). 911–912. 1 indexed citations
14.
Mayo, Donald R., et al.. (1991). Evaluation of a commercial measles virus immunoglobulin M enzyme immunoassay. Journal of Clinical Microbiology. 29(12). 2865–2867. 12 indexed citations
15.
Weymouth, Lisa A., et al.. (1990). Cytomegalovirus Antibody in the Elderly. Intervirology. 31(2-4). 223–229. 13 indexed citations
16.
Lee, Sin Hang, et al.. (1989). Comparative Studies of Three Serologic Methods for the Measurement of Mycoplasma pneumoniae Antibodies. American Journal of Clinical Pathology. 92(3). 342–347. 12 indexed citations
17.
Mayo, Donald R., et al.. (1985). Rapid herpes simplex virus detection in clinical samples submitted to a state virology laboratory. Journal of Clinical Microbiology. 21(5). 768–771. 21 indexed citations
18.
Mayo, Donald R., et al.. (1985). Cytomegalovirus antibody detection by three commercially available assays and complement fixation. Diagnostic Microbiology and Infectious Disease. 3(5). 455–459. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026